Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is prevalent in 20–25% of the general population and is associated with metabolic risk factors such as obesity, diabetes mellitus, and dyslipidemia. Histologically, NAFLD ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), fibrosis, and cirrh...
Saved in:
Main Authors: | Elena Buzzetti, Rosa Lombardi, Laura De Luca, Emmanuel A. Tsochatzis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2015/343828 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
by: Hongjie Ou, et al.
Published: (2019-01-01) -
Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
by: Hannes Hagström, et al.
Published: (2018-01-01) -
Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease
by: Kadir Ozturk, et al.
Published: (2016-01-01) -
Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01) -
Update on Ppar𝜸 and Nonalcoholic Fatty Liver Disease
by: Gene P. Ables
Published: (2012-01-01)